Sunridge Receives Reorder on $4 Million Indian Contract

Oct 13, 2010, 09:00 ET from Sunridge International

FOUNTAIN HILLS, Ariz., Oct. 13 /PRNewswire/ -- Sunridge International (OTC Bulletin Board: SNDZ), announced today it received an order for additional inventory from New Amsterdam Marketing Corporation, its exclusive distributor in India and Bangladesh.  New Amsterdam personnel are currently on a two-week marketing road show in multiple cities throughout India and Bangladesh.  New Amsterdam's personnel is accompanied by Leo D. Bores M.D., a medical consultant for Sunridge.  Together, they are training doctors, treating patients and providing informational seminars to the public.

Midway through the road show, sales have already surpassed inventory, making it necessary to reorder additional equipment and supplies to meet the demand.

Glaucoma is the second leading cause of blindness, affecting over 70 million people worldwide. PNT has been proven (through studies completed over the last 10 yrs) to be a safe, effective, non-invasive and a cost effective alternative for treatment for glaucoma and ocular hypertension. The 2-minute treatment has been developed, patented, and distributed by Sunridge International, wholly owned subsidiary, Ophthalmic International (www.oi-pnt.com).

For full details of PNT and its application, we invite you to visit Sunridge International's website at www.sunridgeint.com.

   CONTACT:

   Jeff Smith, Sunridge International

   T:  +1-480-837-6165

   e-mail: info@sunridgeint.com

   MEDIA:

   Victor Webb, Marston Webb International

   T: (212) 684-6601

   e-mail: marwebint@cs.com

SOURCE Sunridge International



RELATED LINKS

http://www.sunridgeint.com